Benzodiazepines Associated With Higher Risk of Dementia (BMJ / NHS Choices)

[A version of this item appears in: Dementia and Elderly Care: the Latest Evidence Newsletter (RWHT), Volume 3 Issue 3, October 2012].

Summary

Benzodiazepines (sedatives / sleeping pills prescribed for sleeping problems and anxiety) taken by millions of people appear to be linked to dementia. A French study followed over one thousand elderly adults, free from dementia initially, for 15 years. Those who took benzodiazepines after the first three years of the study were 60% more likely to develop dementia.

This study does not “prove” the causal link between benzodiazepines and dementia, because there may – just hypothetically – be underlying conditions or biological processes which cause people to be prescribed sleeping tablets. Similarly, disturbed sleep could be an initial sign of dementia; although the researchers tried to offset this confounding factor of any pre-symptoms (“prodrome”) of dementia by selecting recruits who did not start taking sleeping tablets until at least the third year of the study.

This research demonstrates an association between the uptake of benzodiazepine use among elderly adults and the risk of developing dementia. Some potential limitations of this study are:

  • The actual number of new users of benzodiazepines after the third year of study was small (95), hence limiting the ability to detect significant differences in dementia risk between users and non-users.
  • While the researchers attempted to adjust for confounding variables, it is difficult to exclude them all; it is hypothetically possible that the apparent dementia risk may reflect underlying conditions or biological processes in the brain. This study did not investigate other mental health problems such as anxiety. Reverse causation may be at work, such that the early symptoms of dementia cause the use of sleeping pills.

Given the risks, it has been concluded that benzodiazepines should be a “treatment of last resort” for severe acute insomnia or anxiety, and should be taken for no longer than two-to-four weeks.

Full Text Link (a)

Reference

Widely used sleeping pill ‘increases dementia’ risk. London: NHS Choices, Behind the Headlines, September 28th 2012.

Full Text Link (b)

Reference

Billioti de Gage, S. Bégaud, B. [and] Bazin, F. [et al] (2012). Benzodiazepine use and risk of dementia: prospective population based study. BMJ. September 27th 2012. 345: e6231.

Advertisements

About Dementia and Elderly Care News

Dementia and Elderly Care News. Wolverhampton Medical Institute: WMI. (jh)
This entry was posted in Acute Hospitals, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Quick Insights, Universal Interest and tagged , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.